Intestinal Absorption of Oxalate and Calcium in Patients with Jejunoileal Bypass

REFERENCES

• Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986; 116: 455–460.
   PubMed Web of Science ®Google Scholar
• Backman L, Nordenvall B, Hallberg D. The incidence of urinary tract calculi after small intestinal bypass operations for treatment of obesity. Urol Res 1979; 7: 189–195.
   PubMedGoogle Scholar
• Backman L, Wiklund B, Svane B, Hallberg D. A roentgenological study of the small intestine after intestinal bypass operation for treatment of obesity. Int J Obes 1982; 6: 205–210.
   PubMed Web of Science ®Google Scholar
• Barilla DE, Notz C, Kennedy D, Pak CYC. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Am J Med 1978; 64: 579–585.
   PubMed Web of Science ®Google Scholar
• Benson L, Ljunghall S, Groth T, Falk H, Hvarfner A, Rastad J, Wide L, Åkerström G. Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements. Ups J Med Sci 1987; 92: 147–176.
   PubMed Web of Science ®Google Scholar
• Bjôrneklett A, Viddall KO, Midtvedt T, Nygaard K. Intestinal and gastric bypass. Changes in intestinal microecology after surgical treatment of morbid obesity in man. Scand J Gastroenterol 1981; 16: 681–687.
   PubMed Web of Science ®Google Scholar
• Caspary WF. Intestinal oxalate absorption. Res Exp Med 1977; 171: 13–24.
   PubMedGoogle Scholar
• Colton T. Statistics in medicine. Boston: Little, Brown and Company, 1974.
   Google Scholar
• Compston J, Laker MF, Woodhead JS, Gazet JC, Horton LVL, Ayers AB, Bull HJ, Pilkington TRE. Bone disease after jejunoileal bypass for obesity. Lancet 1978; ii: 1–4.
   Google Scholar
• Danö P, Lenz K. Change of bile acid metabolism and absorption of vitamin B12 after intestinal shunt operation in obesity. A comparison of three types of operation. Scand J Gastroent 1974; 9: 159–165.
   PubMed Web of Science ®Google Scholar
• Dobbins JW. Nephrolithiasis associated with intestinal disease. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, eds. Urolithiasis and related clinical research. New York: Plenum Press, 1985: 119–126.
   Google Scholar
• Dobbins JW, Binder HJ. Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 1976; 70: 1096–1100.
   PubMed Web of Science ®Google Scholar
• Dobbins JW, Binder HJ. Importance of the colon in enteric hyperoxaluria. N Engl J Med 1977; 296: 298–301.
   PubMed Web of Science ®Google Scholar
• Dowling RH, Rose GA, Sutor DJ. Hyperoxaluria and renal calculi in ileal disease. Lancet 1971; i: 1103–1105.
   Google Scholar
• Drenick EJ, Stanley TM, Wills CE. Renal damage after intestinal bypass. Int J Obes 1981; 5: 501–508.
   PubMed Web of Science ®Google Scholar
• Earnest DL. Enteric hyperoxaluria. Adv Int Med 1979; 24: 407–427.
   PubMedGoogle Scholar
• Earnest DL, Johnson G, Williams HE, Admirand WH. Hyperoxaluria in patients with ileal resection, an abnormality in dietary oxalate absorption. Gastroenterology 1974; 66: 1114–1122.
   PubMed Web of Science ®Google Scholar
• Gregory JG. Hyperoxaluria and stone disease in the gastrointestinal bypass patient. Urol Clin N Am 1981; 8: 331–351.
   PubMed Web of Science ®Google Scholar
• Hocking MP, Duerson M, O'Leary P, Woodward ER. Jejunoileal bypass for morbid obesity. N Engl J Med 1983; 308: 995–999.
   PubMed Web of Science ®Google Scholar
• Hodgkinson A. Oxalic acid in biology and medicine. New York: Academic Press, 1977: 159–192.
   Google Scholar
• Holzbach RT, Weiland RG, Lieber CS, de Carli LM, Kopke KR, Green SG. Hepatic effects of jejunoileal bypass for morbid obesity. Am J Clin Nutr 1977; 30: 43–52.
   PubMed Web of Science ®Google Scholar
• Lindsjö M, Danielson BG, Fellström B, Ljunghall S. Intestinal oxalate and calcium absorption in recurrent stone formers and healthy subjects. Scand J Urol Nephrol 1989; 23: 55–59.
   PubMed Web of Science ®Google Scholar
• Ljunghall S, Backman U, Danielson BG, Johansson G, Jung B, Källsén R, Wibell L, Wålinder O. Mechanisms of hypercalciuria in recurrent renal stone formers. Scand J Urol Nephrol 1977; Suppl 41: 77–96.
   Google Scholar
• Nordenvall B, Backman L, Larsson L, Tiselius HG. Urine composition following jejunoileal bypass. Eur Urol 1983; 149: 35–39.
   Google Scholar
• Nordin BEC, Horsman A, Aaron J. Diagnostic procedures. In: Nordin BEC, ed. Calcium, phosphate and magnesium metabolism. Edinburgh: Churchill Livingstone, 1976: 469–524.
   Google Scholar
• Olthuis FMFG, Markslag AMG, Klein Elhorst JT, Krugers Dagneaux PGLC. Urinary oxalate estimation. Clin Chim Acta 1977; 75: 123–128.
   PubMed Web of Science ®Google Scholar
• Pabico RC, McKenna BBA, Freeman RB. Renal tubular dysfunctions in patients with idiopathic calcium nephrolithiasis. Mineral Electrolyte Metab 1987; 13: 462–468.
   PubMedGoogle Scholar
• Payne JH, DeWind LT. Surgical treatment of obesity. Am J Surg 1969; 118: 141–147.
   PubMed Web of Science ®Google Scholar
• Prenen JAC, Boer P, Dorhout Mees EJ. Absorption kinetics of oxalate-rich food in man. Am J Clin Nutr 1984; 40: 1007–1010.
   PubMed Web of Science ®Google Scholar
• Robertson WG, Peacock M. The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria? Nephron 1980; 26: 105–110.
   PubMed Web of Science ®Google Scholar
• Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB. Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978; 50: 449–454.
   PubMedGoogle Scholar
• Smith LH, Fromm H, Hofmann AF. Acquired hyperoxaluria, nephrolithiasis and intestinal disease: Description of a syndrome. N Engl J Med 1972; 286: 1371–1375.
   PubMed Web of Science ®Google Scholar
• Stauffer J. Hyperoxaluria and intestinal disease. The role of steatorrhoea and dietary calcium in regulating intestinal oxalate absorption. Dig Dis 1977; 22: 921–928.
   Web of Science ®Google Scholar
• Tiselius H-G. Oxalate and renal stone formation. Scand J Urol Nephrol 1980; Suppl 53: 135–146.
   Google Scholar
• Tiselius H-G. An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 1982; 122: 409–418.
   PubMed Web of Science ®Google Scholar
• Tiselius H-G, Ahlstrand C, Lundström B, Nilsson MA. 14C-oxalate absorption by normal persons, calcium oxalate stone formers and patients with surgically disturbed intestinal function. Clin Chem 1981; 27: 1682–1685.
   PubMed Web of Science ®Google Scholar
• Tiselius H-G, Larsson L. Studies on urine composition in patients with calcium oxalate stone disease. In: Schwille PO, Smith LH, Robertson WH, Vahlensieck W, eds. Urolithiasis and related clinical research. New York: Plenum Press, 1985: 291–294.
   Google Scholar
• Welshman SG, McCambridge H. The estimation of citrate in serum and urine using a citrate lyase technique. Clin Chim Acta 1973; 46: 243–246.
   PubMed Web of Science ®Google Scholar